ArticleOncology reports2016

Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.

Lahong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.